Factors in AIDS Dementia Complex Trial Design: Results and Lessons from the Abacavir Trial

Bruce J Brew, Mark Halman, Jose Catalan, Ned Sacktor, Richard W Price, Steve Brown, Hamp Atkinson, David B Clifford, David Simpson, Gabriel Torres, Colin Hall, Christopher Power, Karen Marder, Justin C Mc Arthur, William Symonds and Carmen Romero

PLOS Clinical Trials, 2007, vol. 2, issue 3, 1-10

Abstract: Objectives: To determine the efficacy of adding abacavir (Ziagen, ABC) to optimal stable background antiretroviral therapy (SBG) to AIDS dementia complex (ADC) patients and address trial design. Design: Phase III randomized, double-blind placebo-controlled trial. Setting: Tertiary outpatient clinics. Participants: ADC patients on SBG for ≥8 wk. Interventions: Participants were randomized to ABC or matched placebo for 12 wk. Outcome Measures: The primary outcome measure was the change in the summary neuropsychological Z score (NPZ). Secondary measures were HIV RNA and the immune activation markers β-2 microglobulin, soluble tumor necrosis factor (TNF) receptor 2, and quinolinic acid. Results: 105 participants were enrolled. The median change in NPZ at week 12 was +0.76 for the ABC + SBG and +0.63 for the SBG groups (p = 0.735). The lack of efficacy was unlikely related to possible limited antiviral efficacy of ABC: at week 12 more ABC than placebo participants had plasma HIV RNA ≤400 copies/mL (p = 0.002). There were, however, other factors. Two thirds of patients were subsequently found to have had baseline resistance to ABC. Second, there was an unanticipated beneficial effect of SBG that extended beyond 8 wk to 5 mo, thereby rendering some of the patients at baseline unstable. Third, there was an unexpectedly large variability in neuropsychological performance that underpowered the study. Fourth, there was a relative lack of activity of ADC: 56% of all patients had baseline cerebrospinal fluid (CSF) HIV-1 RNA

Date: 2007
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://journals.plos.org/plosclinicaltrials/artic ... journal.pctr.0020013 (text/html)
https://journals.plos.org/plosclinicaltrials/artic ... 20013&type=printable (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:plo:pctr00:0020013

DOI: 10.1371/journal.pctr.0020013

Access Statistics for this article

More articles in PLOS Clinical Trials from Public Library of Science
Bibliographic data for series maintained by plosone ().